FDA — authorised 14 April 1967
- Marketing authorisation holder: ABBVIE
- Status: approved
🇺🇸 Choloxin in United States
FDA authorised Choloxin on 14 April 1967
Marketing authorisations
FDA — authorised 14 April 1967
- Application: NDA012302
- Marketing authorisation holder: ABBVIE
- Local brand name: CHOLOXIN
- Indication: TABLET — ORAL
- Status: approved
Choloxin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Choloxin approved in United States?
Yes. FDA authorised it on 14 April 1967; FDA authorised it on 14 April 1967.
Who is the marketing authorisation holder for Choloxin in United States?
ABBVIE holds the US marketing authorisation.